FDA Clears YorLabs Intracardiac Imaging System

YorLabs, a company pioneering next-gen intracardiac imaging for electrophysiology (EP) and interventional cardiology (IC) procedures, has earned U.S. Food and Drug Administration (FDA) 510(k) clearance for its YorLabs intracardiac imaging system.

The first-of-its-kind (according to the company) zero-capex ultrasound platform aims to simplify workflow, reduce cost, and boost efficiency in the cath lab.

The system offers single-operator control and provides high-resolution, real-time imaging for a range of intracardiac procedures. Its compact, wireless system integrates into cath labs, representing a leap forward in how therapy in the heart is visualized and guided.

The use of intracardiac echocardiography (ICE) has surged as clinicians seek greater visualization, safety, and precision during transseptal access, ablation, and left atrial appendage closure procedures. YorLabs’ platform was engineered to meet this demand by delivering advanced imaging performance in a zero-capital, zero-footprint format that can be deployed in any lab.

The system’s Zero CapEx deployment eliminates large upfront capital purchases. Single-operator control reduces cognitive load and streamlines coordination during procedures. The software-defined platform fits into existing cath lab environments, and high-definition intracardiac imaging offers real-time visualization to guide complex interventions.

YorLabs expects to begin limited U.S. release in 2026, followed by broader commercial rollout and clinical partnerships with leading EP and IC centers of excellence.

“This clearance represents a major milestone for YorLabs and validates our vision to reimagine intracardiac imaging from the ground up,” said Gregory D. Casciaro, president and CEO of YorLabs. “For decades, cath labs have relied on legacy imaging systems that are expensive, cumbersome, and poorly integrated into procedural workflows. Our platform delivers the same performance as capital-intensive systems, but in a simpler, smarter, and more accessible way.”